CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $2.66M invested in Can-Fite BioPharma in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$461K
2
+$238K
3
+$77.7K
4
Creative Planning
Creative Planning
Kansas
+$14K
5
VKH
Virtu KCG Holdings
New York
+$9.18K

Top Sellers

1
-$309K
2
-$58K
3
-$32K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$25K
5
Citigroup
Citigroup
New York
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.66M
2
$705K
3
$113K
4
$108K
5
$52K
6
$14K
7
$6K
8
$4K
9
$3K
10
–
11
–
12
–
13
–